Mouth ulcers can be avoided by preventing tissue injury, avoiding irritating foods, and keeping good dental hygiene. Aside from the traditional way, oral ulcers are treated using a variety of medications. The expansion of this mouth ulcer treatment market is being driven by an older population and an increase in the occurrence of mouth ulcers. Mouth ulcers, also known as canker sores, are painful sores that develop on the lips, cheeks, tongue, floor, the roof of the mouth, and gums. Some individuals may find it difficult to eat, drink, or brush their teeth due to mouth ulcers. Most mouth ulcers are benign and recurrent, clearing up on their own within 1-2 weeks. Acidic foods, biting the tongue or inside of the cheek, braces, poor-fitting dentures, and other apparatus that rub against the mouth and gums, vitamin deficiency, stress, anxiety, infections, and maybe a sign of other diseases such as Crohn's disease, celiac disease, or HIV are all common causes of mouth ulcers.
Mouth Ulcer Treatment Market Segment Insights
The mouth ulcer treatment market has been segmented on basis of drug type, formulation, and indication.
Mouth Ulcer Treatment Drug Type Insights
On basis of drug type, the market is segmented into corticosteroid, antihistamine, antimicrobial, analgesic, and anesthetic.
Mouth Ulcer Treatment Formulation Insights
Based on formulation, the market is segmented into gel, mouthwash, ointment, spray, and lozenges.
Mouth Ulcer Treatment Indication Insights
Based on indication market is segmented into Aphthous Stomatitis, Oral Lichen Planus and Others.
Mouth Ulcer Treatment Regional Insights
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The mouth ulcer treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The mouth ulcer treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.
On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and the Middle East and Africa. North America market is anticipated to dominate the mouth ulcer treatment market due to advanced technology made in diagnostic procedures of oral and dental care. Growing awareness among consumers regarding the availability of mouth ulcer treatment is the key share to increase the growth of the market in North America. Europe is anticipated to drive the growth of mouth ulcer treatment in upcoming years due to increasing incidences of an aging population suffering from mouth ulcer. Asia-Pacific is projected to register a robust growth due to increasing initiatives of government regarding mouth ulcer and increasing patients with mouth ulcer cases. The Middle East and Africa is expected to account for the lowest market share in the market due to lack of advanced technology and poor medical facilities in developing economies in this region.
Recent Development
Manx Healthcare introduced Oral Soothe and Sore Throat 0.15 percent w/v mouthwash in September 2021, an over-the-counter product used to treat mouth and throat pain caused by a variety of medical issues, such as dental surgery, tonsillitis, gum disease, mouth ulcers, and other mouth and throat conditions.
GELX ORAL GEL, a Zinc-Taurine bioactive barrier therapy for the management and reduction of oral discomfort associated with oral mucositis, was launched in May 2020 by US WorldMeds, LLC.
Key players
Key players in the mouth ulcer treatment market are
- Pfizer, Inc.
- Church & Dwight Co. Inc.
- 3M
- Taro Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company
- BLISTEX, INC.
- GlaxoSmithKline plc.
- ECR Pharmaceuticals
- Sannova
- Reckitt Benckiser
- Sunstar
- Blairex Laboratories
- Sanjin Pharmaceutical
- Joincare Pharmaceutical
- Sinclair Pharma
- Colgate-Palmolive Company
Mouth Ulcer Treatment Market Segmentation
Mouth Ulcer Treatment Drug Type Outlook
- Corticosteroid
- Antihistamine
- Antimicrobial
- Analgesic
- Anesthetic
Mouth Ulcer Treatment Formulation Outlook
- Gel
- Mouthwash
- Ointment
- Spray
- Lozenges
Mouth Ulcer Treatment Indications Outlook
- Aphthous Stomatitis
- Oral Lichen Planus
- Others
Mouth Ulcer Treatment Regional Outlook
Americas
- North America
- US
- Canada
- South America
Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Middle East & Africa